Skip to main content
OpenTrials
Completed

NCT Number: NCT02969512

Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER)

Osteoarthritis (OA), leading to hip replacement, is a leading contributor to global mobility impairment. Given the boom in the older demographic it is not surprising that there is an 11% increased demand for replacement every 5 years in Canada. Health promotion interventions, such as prehabilitation, defined as pre-surgical education, are vital to optimizing surgical outcomes, reducing hospitalization costs, accelerating rehabilitation, and reducing patient discomfort and pre-operative anxiety. HIPPER is a 2-year randomized controlled trial (RCT) that will assess feasibility indicators and clinical outcomes of online prehab education modules compared to online educational webinars. The feasibility indicators (process, resource, management, and treatment issues) and clinical outcomes (physical function, anxiety, depression, pain, daily activities, self-efficacy, and health related quality of life) will be assessed among Vancouver-dwelling older adults aged > 50 years, with advanced hip osteoarthritis. The findings will lead to the refinement of the design protocol in order to evaluate a contemporary, standardized, and geographically accessible prehab education program in a large multi-site RCT.

Completed

Looking for future studies?

Notify Me

Key information

Age range

50 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

GF Strong Rehabilitation Centre

Vancouver, British Columbia, V5Z 2G9, Canada

About this study

This feasibility study will use a single-site, parallel group evaluator blind RCT. Subjects (N=40) will be randomly assigned to the experimental (HIPPER n=20) or control (n=20) groups.The experimental group will receive the interactive online HIPPER intervention consisting of 12 modules (~20 mins/module). The control group is usual practice consisting of a 2 hr online large group educational webinar. Feasibility indicators (i.e. recruitment and retention; subject burden; safety; intervention administration/adherence; perceived benefit) will be evaluated as binary outcomes against pre-set parameters reflecting viability for a multi-site large-scale RCT. The primary clinical outcome of interest when assessing effect size for the eventual RCT is the Hospital Anxiety and Depression Scale-Anxiety. Secondary clinical outcomes include measures of pain, function, daily activities, self-efficacy, equipment checklist, system usability scale, environmental setup, physical activity, and health related quality of life.

Upon successful screening/enrollment and baseline data collection (T1) the Study Coordinator will contact the statistician by telephone or email and obtain group assignment within 48 hours. Subjects will be randomized using a 1:1 allocation ratio between groups. A central computerized randomization process will be designed by the statistician, with an undisclosed block size. To address bias, subjects will be instructed not to discuss their program and Testers will reinforce this point at each session. T1 data will be collected at our clinic while the follow up data collected 7-10 days prior to surgery (T2), and 30 days post-surgery (T3).

The findings from the study will be summarized and mailed to each participant upon study completion. HIPPER and control group assessments will be held at GF Strong Rehabilitation Centre and at subject's homes.

The outcome will lead to the refinement of the design protocol in order to robustly evaluate a contemporary, standardized, and geographically accessible prehabilitation education program. Ultimately, HIPPER may be found to have significant individual and social (health system level) benefits.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Community-dwelling participants with advanced hip OA will be included if they:

  • are living in the greater Vancouver region;
  • are aged 50 years or older;
  • are scheduled to have a single THR in 12 weeks or later;
  • have access to the internet

Exclusion criteria

  • cannot communicate and complete questionnaires in English;
  • anticipate a health condition or procedure that contraindicates their THR surgery;
  • are actively receiving physical therapy for their hip symptoms;
  • have had a previous THR.

Treatment and study plan

HIPPER

Other

Participants can complete the online educational modules at home or another location with internet access. The total time to complete all of the modules is about 2 hours and 30 minutes.

Other names: Behavioral: Online prehab education

OASIS Online Educational Webinars

Other

2-hour online educational large group sessions

Other names: Behavioral: large group education sessions

Primary outcomes

  1. Hospital Anxiety and Depression Scale - Anxiety Subscale (HADS-A)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Hospital Anxiety and Depression Scale (HADS-A) measures anxiety symptoms. The anxiety subscale (HADS-A) has 7 items, each rated 0-3 and summed to a total of 0-21. Higher scores indicate worse outcomes (greater anxiety).

Secondary outcomes

  1. Hospital Anxiety and Depression Scale - Depression Subscale (HADS-D)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Hospital Anxiety and Depression Scale (HADS-D) measures depression symptoms. The depression subscale (HADS-D) has 7 items, each rated 0-3 and summed to a total of 0-21. Higher scores indicate higher levels of depression.

  2. Oxford Hip Score (OHS)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Oxford Hip Score (OHS) measures pain and function in patients with hip osteoarthritis. It has 12 items, each rated 0-4, summed to a total of 0-48. Higher scores indicate lower levels of disability.

  3. Change in Self-Efficacy for Rehabilitation Outcome Scale (SER)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Self-Efficacy for Rehabilitation Outcome Scale (SER) measures confidence in performing rehabilitation activities. It has 12 items, each rated 0-10, summed to a total of 0-120. Higher scores indicate greater self-efficacy.

  4. System Usability Scale (SUS)

    Time frame: T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery); Completed only by participants in the HIPPER group.

    The System Usability Scale (SUS) measures perceived usability of a system. It has 10 items rated on a 5-point scale; item scores are converted, summed, and multiplied by 2.5 to give a total of 0-100. Higher scores indicate better perceived usability.

  5. Hip Disability and Osteoarthritis Outcome Score - Activities of Daily Living Subscale (HOOS-ADL)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Hip Disability and Osteoarthritis Outcome Score (HOOS) Activities of Daily Living (ADL) subscale measures difficulty with daily activities in patients with hip osteoarthritis. It has 17 items, each rated on a five-point Likert scale (0 = none to 4 = extreme difficulty), summed to a total ranging from 0 to 68. Higher scores indicate greater difficulty with daily activities.

  6. Physical Activity Scale for the Elderly (PASE)

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Physical Activity Scale for the Elderly (PASE) measures self-reported physical activity over the past 7 days in older adults. Scores are a weighted sum of time spent across activity types, ranging from 0 to 400 or more. Higher scores indicate greater physical activity.

  7. EuroQol 5-Dimension 5-Level (EQ-5D-5L) Index Score

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The EuroQol 5-Dimension 5-Level (EQ-5D-5L) measures health-related quality of life across five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Responses were converted to a single utility index ranging from -0.285 to 1 (extreme problems on all dimensions) to 1 (full health). Higher scores indicate better health-related quality of life.

  8. Equipment Checklist

    Time frame: T1 (Baseline); T2 (7-10 days before surgery); T3 (Post-Intervention, 30 days after surgery)

    The Equipment Checklist included recommended equipment and mobility aids for total hip replacement. This checklist was developed in accordance with current guidelines and clinical recommendations. Participants indicated which items they had obtained. The reported value is the number of items obtained per participant. Higher scores indicate more recommended equipment obtained.

  9. 30-second Chair-Stand Test

    Time frame: T1 (Baseline); T2 (7-10 days before surgery).

    The 30-Second Chair-Stand Test measures lower-body strength and endurance. Participants stand fully from a seated position and sit back down as many times as possible within 30 seconds. The score is the number of completed sit-to-stand repetitions. Higher scores indicate better lower-body strength and function.

Sponsors and collaborators

Lead sponsor

University of British Columbia

Other

Collaborators

  • Canadian Institutes of Health Research (CIHR)

Registry information

Official study title

Feasibility of the Hip Instructional Prehabilitation Program for Enhanced Recovery (HIPPER) Intervention Protocol: An eHealth Approach for Pre-surgical Hip Replacement Education

Acronym: HIPPER

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Nov 21, 2016
Registry last updated
Aug 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.